0000899243-19-002064.txt : 20190128
0000899243-19-002064.hdr.sgml : 20190128
20190128190106
ACCESSION NUMBER: 0000899243-19-002064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190124
FILED AS OF DATE: 20190128
DATE AS OF CHANGE: 20190128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PEREZ ROBERT J
CENTRAL INDEX KEY: 0001263230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 19546801
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER ST.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZAFGEN, INC.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
BUSINESS PHONE: 617-622-4003
MAIL ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-24
0
0001374690
ZAFGEN, INC.
ZFGN
0001263230
PEREZ ROBERT J
C/O ZAFGEN, INC.,
175 PORTLAND STREET
BOSTON
MA
02114
1
0
0
0
Common Stock
2019-01-24
4
A
0
4423
4.38
A
5322
D
Common Stock
5564
I
See Footnote
Stock Option (Right to Buy)
4.38
2019-01-24
4
A
0
5717
0.00
A
2029-01-24
Common Stock
5717
5717
D
The common stock was acquired in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Unit Award and the restrictions lapse over a period of one year starting January 1, 2019 on a quarterly basis in arrears. Each restricted stock unit represents a contingent right to receive one share of Zafgen, Inc. common stock.
These securities are held directly by Vineyard Sound Advisors, LLC, of which Reporting Person is the sole member.
The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2019 on a quarterly basis in arrears.
/s/ Shoaib Ghias, Attorney-In-Fact
2019-01-28